Analysts Set Option Care Health, Inc. (NASDAQ:OPCH) PT at $30.08

Posted by on Jul 25th, 2026

Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) has received an average rating of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $30.0769.

A number of analysts have commented on the stock. Barrington Research lowered their target price on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a report on Friday, May 1st. UBS Group restated a “buy” rating on shares of Option Care Health in a research report on Tuesday, June 16th. Morgan Stanley set a $28.00 price objective on Option Care Health in a research note on Wednesday, May 6th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $26.00 price objective on shares of Option Care Health in a report on Friday, May 1st.

Check Out Our Latest Research Report on Option Care Health

Insider Transactions at Option Care Health

In other news, CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the purchase, the director directly owned 450,000 shares in the company, valued at $9,634,500. The trade was a 8.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders purchased 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Several hedge funds have recently bought and sold shares of the company. Royal Bank of Canada grew its holdings in shares of Option Care Health by 20.7% in the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after buying an additional 39,661 shares during the period. AQR Capital Management LLC increased its position in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after buying an additional 25,777 shares in the last quarter. Empowered Funds LLC acquired a new stake in Option Care Health during the 1st quarter worth $208,000. Invesco Ltd. raised its stake in Option Care Health by 2.7% during the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after buying an additional 7,678 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after acquiring an additional 1,183 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Up 2.8%

Shares of NASDAQ OPCH opened at $21.66 on Wednesday. The firm has a market capitalization of $3.40 billion, a PE ratio of 16.79, a price-to-earnings-growth ratio of 1.17 and a beta of 0.65. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The firm’s 50-day moving average is $21.32 and its 200-day moving average is $27.13.

Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the firm posted $0.40 earnings per share. Option Care Health’s revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts expect that Option Care Health will post 1.64 EPS for the current year.

Option Care Health Company Profile

(Get Free Report)

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.

Featured Stories

Analyst Recommendations for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.